The TRITON versus PLATO trials: Differences beyond platelet inhibitionSEREBRUANY, Victor L.Thrombosis and haemostasis. 2010, Vol 103, Num 2, pp 259-261, issn 0340-6245, 3 p.Article

Aggressive chronic platelet inhibition with prasugrel and increased cancer risks: revising oral antiplatelet regimens?SEREBRUANY, Victor L.Fundamental & clinical pharmacology. 2009, Vol 23, Num 4, pp 411-417, issn 0767-3981, 7 p.Article

Selective serotonin reuptake inhibitors and increased bleeding risk : Are we missing something?SEREBRUANY, Victor L.The American journal of medicine. 2006, Vol 119, Num 2, pp 113-116, issn 0002-9343, 4 p.Article

The PLATO trial: do you believe in magic?SEREBRUANY, Victor L; ATAR, Dan.European heart journal. 2010, Vol 31, Num 7, pp 764-767, issn 0195-668X, 4 p.Article

Viewpoint: Mismatch between the European and American guidelines on oral antiplatelet P2Y₁₂ inhibitors after acute coronary syndromesSEREBRUANY, Victor L; DINICOLANTONIO, James J.Thrombosis and haemostasis. 2013, Vol 110, Num 1, pp 5-10, issn 0340-6245, 6 p.Article

Comparing Ticagrelor Versus Clopidogrel in Patients With a History of Cerebrovascular Disease: A Net Clinical Harm?DINICOLANTONIO, James J; SEREBRUANY, Victor L.Stroke (1970). 2012, Vol 43, Num 12, pp 3409-3410, issn 0039-2499, 2 p.Article

Impact of clopidogrel and potent P2Y₁₂-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A systematic review and meta-analysisARADI, Dániel; KOMOCSI, András; VOROBCSUK, András et al.Thrombosis and haemostasis. 2013, Vol 109, Num 1, pp 93-101, issn 0340-6245, 9 p.Article

Cangrelor infusion is associated with an increased risk for bleeding: Meta-analysis of randomized trialsSEREBRUANY, Victor L; ARADI, Daniel; MOO HYUN KIM et al.International journal of cardiology. 2013, Vol 169, Num 3, pp 225-228, issn 0167-5273, 4 p.Article

Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrelARADI, Dániel; KULICZKOWSKI, Wiktor; ATAR, Dan et al.Thrombosis and haemostasis. 2012, Vol 107, Num 2, pp 338-345, issn 0340-6245, 8 p.Article

Rapid platelet inhibition after a single capsule of Aggrenox®: Challenging a conventional full-dose aspirin antiplatelet advantage?SEREBRUANY, Victor L; MALININ, Alex I; SANE, David C et al.American journal of hematology. 2003, Vol 72, Num 4, pp 280-281, issn 0361-8609, 2 p.Article

Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirinMALININ, Alex I; CALLAHAN, Kevin P; SEREBRUANY, Victor L et al.Thrombosis research. 2001, Vol 104, Num 4, pp 297-299, issn 0049-3848Article

Disbalance between mortality and non-fatal vascular events in the CHAMPION-PHOENIX trial: The cangrelor efficacy challengeSEREBRUANY, Victor L; POKOV, Alex N; FORTMANN, Seth D et al.Thrombosis and haemostasis. 2014, Vol 111, Num 1, pp 3-7, issn 0340-6245, 5 p.Article

Antiplatelet Profiles of the Fixed-Dose Combination of Extended-Release Dipyridamole and Low-Dose Aspirin Compared with Clopidogrel With or Without Aspirin in Patients with Type 2 Diabetes and a History of Transient Ischemic Attack : A Randomized, Single-Blind, 30-Day TrialSEREBRUANY, Victor L; MALININ, Alex I; POKOV, Alex N et al.Clinical therapeutics. 2008, Vol 30, Num 2, pp 249-259, issn 0149-2918, 11 p.Article

Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapyGURBEL, Paul A; O'CONNOR, Christopher M; DALESANDRO, Margaret R et al.The American journal of cardiology. 2001, Vol 87, Num 6, pp 774-777, issn 0002-9149Article

The in-vitro effects of E5555, a protease-activated receptor (PAR)- I antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery diseaseSEREBRUANY, Victor L; KOGUSHI, Motoji; DASTROS-PITEI, Daniela et al.Thrombosis and haemostasis. 2009, Vol 102, Num 1, pp 111-119, issn 0340-6245, 9 p.Article

Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery diseaseMALININ, Alex I; ATAR, Dan; CALLAHAN, Kevin P et al.European journal of pharmacology. 2003, Vol 462, Num 1-3, pp 139-143, issn 0014-2999, 5 p.Article

Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy)SEREBRUANY, Victor L; MALININ, Alex I; O'CONNOR, Christopher M et al.The American heart journal. 2003, Vol 146, Num 1, pp 91-98, issn 0002-8703, 8 p.Article

Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirinSANE, David C; MCKEE, Scott A; MALININ, Alex I et al.The American journal of cardiology. 2002, Vol 90, Num 8, pp 893-895, issn 0002-9149Article

Uniform platelet activation exists before coronary stent implantation despite aspirin therapySEREBRUANY, Victor L; CUMMINGS, Charles C; MALININ, Alex I et al.The American heart journal. 2001, Vol 142, Num 4, pp 611-616, issn 0002-8703Article

Platelet function and total length of intracoronary stents : Is there a correlation?CUMMINGS, Charles C; MCKENZIE, Marcus E; HOROWITZ, Eric D et al.Thrombosis research. 2001, Vol 101, Num 2, pp 105-107, issn 0049-3848Article

Hemostatic abnormalities in patients with congestive heart failure : Diagnostic significance and clinical challengeDAVIS, Christopher J; GURBEL, Paul A; GATTIS, Wendy A et al.International journal of cardiology. 2000, Vol 75, Num 1, pp 15-21, issn 0167-5273Article

Effect of coronary thrombolysis on the plasma concentration of osteonectin (SPARC, BM40) in patients with acute myocardial infarctionSEREBRUANY, Victor L; ATAR, Dan; MURUGESAN, Selva R et al.Journal of thrombosis and thrombolysis. 2000, Vol 10, Num 2, pp 197-202, issn 0929-5305Article

Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. CommentarySEREBRUANY, Victor L; GOTO, Shinya; LORDKIPANIDZE, Marie et al.European heart journal. 2008, Vol 29, Num 23, issn 0195-668X, 2833-2834, 2877-2885 [11 p.]Article

Does heart failure etiology, New York Heart Association class, or ejection fraction affect the ability of clopidogrel to inhibit heightened platelet activity?MALININ, Alex I; OSHRINE, Benjamin R; SANE, David C et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 2, pp 91-96, issn 0957-5235, 6 p.Article

Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) Platelet substudySEREBRUANY, Victor L; MALININ, Alex I; CALLAHAN, Kevin P et al.The American heart journal. 2003, Vol 145, Num 4, pp 636-642, issn 0002-8703, 7 p.Article